| ²é¿´: 704 | »Ø¸´: 0 | ||
á¯ðÎ½ð³æ (ÖøÃûдÊÖ)
ÐØÓм¤À×£¬ÃæÈçÆ½ºþ£¡
|
[ÇóÖú]
Çó¸ÊÁ×Ëᵨ¼îGPCµÄPharmaºÍnewport¼ìË÷½á¹û
|
|
²àÖØÓÚÊг¡£¬³§¼Ò£¬¼Û¸ñ£¬ÏúÊÛÁ¿£¬Ç÷ÊÆ£¬×¨Àû±£»¤ºÍºÏ³É¡£ ²»ÒªÁÙ´²£¬Ò©ÀíºÍÒ©´úµÄÄÚÈÝ¡£ Ò©Æ·Ãû£º¸ÊÁ×Ëᵨ¼î GPC CASºÅ: 28319-77-9 Ó¢ÎÄÃû³Æ: Choline glycerophosphate Ó¢ÎÄͬÒå´Ê:GPC;Brezal;L-¦Á-GPC;Cereton;Delecit;Alpha GPC;Cholicerin;Cholitiline;CHOLINE ALFOSCERATE;glycerophosphocholine ÖÐÎÄÃû³Æ:¸ÊÁ×Ëᵨ¼î GPC ÖÐÎÄͬÒå´Ê:¸ÊÁ×Ëᵨ¼î;¸ÊÓÍÁ×Ëᵨ¼î;¸ÊÓÍÁ×õ£µ¨¼î;¦¡-¸ÊÓÍÁ×ËáÄ‘û|;¦¡-¸ÊÓÍÁ×ËáÄ‘û|;¸ÊÁ×Ëᵨ¼î GPC;L-¦¡-¸ÊÓÍÁ×õ£µ¨¼î;L-¦¡¸ÊÓÍÁ×Ëá(õ£)µ¨¼î;1-¦¡-¸ÊÓÍ-3-Á×Ëᵨ¼î;SN-¸ÊÓÍ»ù-3-µ¨¼îÁ×Ëá ·Ö×Óʽ: C8H20NO6P ·Ö×ÓÁ¿: 257.22 |
» ²ÂÄãϲ»¶
WoSÒ»ÇøFrontiers in Genome Editing»ùÒò±à¼·½·¨ÓëÓ¦Ó÷½ÏòרÌâÑû¸å£¨Ó°ÏìÒò×Ó4.9£©
ÒѾÓÐ0È˻ظ´
WoSÒ»ÇøFrontiers in Genome Editing»ùÒò±à¼·½·¨ÓëÓ¦Ó÷½ÏòרÌâÑû¸å£¨Ó°ÏìÒò×Ó4.9£©
ÒѾÓÐ0È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ200È˻ظ´
WoSÒ»ÇøFrontiers in Genome Editing»ùÒò±à¼·½·¨ÓëÓ¦Ó÷½ÏòרÌâÑû¸å£¨Ó°ÏìÒò×Ó4.9£©
ÒѾÓÐ0È˻ظ´
WoSÒ»ÇøFrontiers in Genome Editing»ùÒò±à¼·½·¨ÓëÓ¦Ó÷½ÏòרÌâÑû¸å£¨Ó°ÏìÒò×Ó4.9£©
ÒѾÓÐ0È˻ظ´
Éú·À¾úµÄÅèÔÔ·ÀЧʵÑé
ÒѾÓÐ1È˻ظ´
Çë½Ì´óÀÐÀ©É¢ÎÊÌâ
ÒѾÓÐ5È˻ظ´
¹òÇóÒ»Ö§AAV293ϸ°û
ÒѾÓÐ1È˻ظ´
ÖÐÎÄͶ¸å¡°Ö×ÁöÃâÒß¡±Ïà¹Ø
ÒѾÓÐ6È˻ظ´
2025ÄêҩѧרҵÇóµ÷¼Á
ÒѾÓÐ1È˻ظ´
292ҩѧµ÷¼Á
ÒѾÓÐ1È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
ÕÒµ½Ò»Ð©Ïà¹ØµÄ¾«»ªÌû×Ó£¬Ï£ÍûÓÐÓÃŶ~
´ó¼ÒÓÐÔÚ×ö¸ÊÁ×Ëᵨ¼î£¨GPC£©µÄÂð£¿Õâ¸öÆ·ÖÖÔõôÑùÊÇ·ñ¿ÉÒÔ½øÐÐÔÁÏÒ©Éú²úÄØ£¿
ÒѾÓÐ17È˻ظ´
ÇóÁ½¸öÒ©Æ·µÄPharmaºÍnewport¼ìË÷½á¹û
ÒѾÓÐ4È˻ظ´
¿ÆÑдÓСľ³æ¿ªÊ¼£¬ÈËÈËΪÎÒ£¬ÎÒΪÈËÈË














»Ø¸´´ËÂ¥

µã»÷ÕâÀïËÑË÷¸ü¶àÏà¹Ø×ÊÔ´